FDA Warning Letter — Exxon

Case 518868 — FEI 3013306132

The FDA took a Warning Letter action against Exxon on Mar 2, 2017 (Glen Rock, NJ). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
Exxon
Date
Mar 2, 2017
Fiscal Year
2017
Product Type
Tobacco
Center
CTP
Location
Glen Rock, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.